SZENF yields 285.71% · PFE yields 6.13%● Live data
📍 SZENF pulled ahead of the other in Year 1
Combined, SZENF + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of SZENF + PFE for your $10,000?
Seazen Group Limited, together with its subsidiaries, engages in the investment, development, and sale of properties in the People's Republic of China. It primarily develops and sells residential properties and mixed-use complexes, as well as provides commercial property management and other services. As of December 31, 2021, the company had total land bank of approximately 138 million square meters. It also provides asset operation and management, information technology, and children entertainment, and cinema management services. In addition, the company offers securities and future brokerage, and money lending services, as well as dealing and advising services of securities. Further, it provides architecture designing services; and designs, manufactures, and sells auto parts. The company was formerly known as Future Land Development Holdings Limited and changed its name to Seazen Group Limited in November 2019. The company was founded in 1996 and is headquartered in Shanghai, the People's Republic of China. Seazen Group Limited is a subsidiary of Wealth Zone Hong Kong Investments Limited.
Full SZENF Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.